Study Design: A prospective study with randomization of 1020 parturients to one of three groups as soon as labor started. In all parturients, anus, introitus and cervix were cultured semiquantitatively. Two groups were treated double-blindly with 10 ml of either a 0.3% chlorhexidine gel or a placebo gel, applicated around the portio and into the fomices. If labor still continued, a second application was given after 10 h. The third group received no treatment. Ear, pharynx and umbilicus of all newborns were also cultured semiquantitatively. Results: Nine hundred and eighty one women were evaluated. The overall incidence of group B strep tococcal carriership was 19.4%. Vertical transmission was 52.4% in the chlorhexidine group, 71.4% in the placebo group and 66.7% in the control group (P = 0.069). When testing the transmission rates for the chlorhexidine versus the combined placebo plus control group (69.3%), the difference was 16.9% (P ~ 0.026). Conclusion: Vaginal disinfection with a chlorhexidine gel during labor modest ly reduces group B streptococcal vertical transmission. Because the method is cheap, simple and safe, it should be considered for routine use. Our results indicate that it may reduce the incidence of early onset group B streptococcal sepsis by 2-32%. 's genital tract [1,2] . Asymptomatic ma ternal genital GBS colonization may be intermittent or temporary rather than permanent and occurs in 4-40% (usually about 20% )) of pregnant women, depending on the population studied and culture technique used [1-3]. The rectum serves as a reservoir for colonization of the vagina, and genital tract isolation rates are reported highest from the lower vagina (introitus) and lowest from the cervix [1,2]. In infants bom of GBS car riers, vertical transmission range from 40-70%, the higher percentage being associated with a high genital inoculum. Despite high prevalence rates for vertical 0301-2115/95/$09.50 routine use, not as a panacea but as a contribution to the prevention o f GBS infections in newborns.
Introduction
Group B /3-hemolytic streptococcus (GBS, Strepto coccus agalactiae) is the leading cause of neonatal sepsis with eventual meningitis and accounts for 10-25% of postpartum maternal bacteremia [1, 2] . Invasive neona tal GBS infections present themselves either as 'early5 (usually within 24 h) or 'late onset* (7 days-3 months) disease. Early onset infections make up two thirds of cases and are usually acquired by vertical transmission transmission, the incidence of early onset GBS infection is only 1-10/1000 live births. Albeit a small group, pre vention is important because of the high mortality rate: 50-70% in older studies and 13-37% in more recent studies [1, 2] , Furthermore, about half of the infants sur viving GBS meningitis are left with permanent neurologic sequelae.
There is no consensus on the best approach to prevent early onset GBS infection [4] . It is important to recog nize perinatal risk factors, including low birthweight, preterm delivery, prolonged rupture of membranes, in trapartum fever and heavy maternal GBS colonization [1, 2, 5] , Infants of mothers with low levels of serogroupspecific antibodies against GBS are at risk [1] . A pro gram of active immunization aimed at pregnant women or, alternatively, at all women in the childbearing years would probably be most efficient in controlling peri natal GBS disease. However, an effective vaccine is not yet available [6] . Antibiotic treatment during pregnancy is not adequate [7] , neither can single-dose penicillin prophylaxis in infants be recommended [8] . Intrapartum prevention with antibiotic therapy (ampicillin, penicillin G) has been shown to reduce GBS vertical transmission [9] [10] [11] [12] [13] [14] [15] [16] . Vaginal chlorhexidine disinfection during labor has been proposed as a simple, cheap and safe [17] alter native without risk for development of bacterial resis tance and only a very low risk for allergic complications [18] [19] [20] . It can be used not only in delivery wards but also in home deliveries and in the developing world. Chlorhexidine might also reduce the transmission of other potential pathogens. Moreover, as compared to antibiotic therapy, chlorhexidine disinfection would ob viate the necessity of selection. The omission of rapid GBS antigen tests would be advantageous as, so far, they lack sufficient sensitivity [21] .
In 1992, chlorhexidine disinfection during labor was reported to reduce excess neonatal morbidity associated with GBS [22] , However, the effect on vertical transmis sion was not investigated. Stimulated by the promising results of a small clinical pilot study [20] , we in vestigated the effect of vaginal chlorhexidine gel dis infection on vertical transmission of GBS in a randomized trial.
Subjects and methods

L Subjects and design
The trial was conducted from February 1991 through November 1992 in the two hospitals with obstetric ser vices in the city of Nijmegen, The Netherlands. Eligible pregnant women received written information on the trial during pregnancy or at admission to the delivery ward. Exclusion criteria were: known GBS carriership (allowing responsible obstetricians to take different pre ventive measures), use of antibiotics during the 4 weeks before admission, planned caesarean section, antepar tum fetal death, suspected congenital abnormalities and immature labor. The protocol was approved by the ethical committees of both institutions and written in formed consent was obtained from all parturients enrolled in the trial.
The goal of the trial was to study the effect of chlorhexidine disinfection on the rate of GBS transmis sion to the neonate. Secondary goals were to study the vertical transmission rates of Escherichia coli> Staphylococcus aureus and Candida albicans, and to es tablish neonatal and maternal morbidity.
Two groups were treated in a double-blind manner with either a chlorhexidine or a placebo gel. To detect any possible effect of treatment with placebo gel, a third group received no treatment at all. A pre-study calcula tion of the required sample size was performed, assum ing the prevalence of GBS among parturients to be 20%. With the probability of making a type I (a) and type II (0) error set at 0.05 and 0.20, respectively, and consider ing that a reduction in assumed normal GBS transmis sion rate of 50% to 25% or less would be of clinical importance, we estimated that data from about 340 de liveries per group would be required for the study. A total of 1020 participating women were randomly assigned, when labor had clearly started, to one of three groups according to a predefined block (10:10:10) allocation scheme.
Intervention
As in our pilot study, we used a viscous gel to apply the chlorhexidine because it adheres well to the mucosa and is a good lubricant [20] . The active gel consisted of chlorhexidine digluconate (3.0 g), hydroxypropylmethylcellulose 4000 centiPoise (20.0 g), 100 ml glycerol, natrium hydroxide to obtain a pH of 7.0, and water to a volume of 1000 ml. After mixing, the viscous aqueous solution was transferred into glass bottles and sterilized (20 min at 120°C). This product was transferred into disposable sterile syringes and stored at 4°C. The placebo gel had the same composition except for the chlorhexidine digluconate and it was handled identical ly. There were no visual differences between the syringes containing the different gels.
For the duration of the trial, all antiseptic solutions and lubricants for obstetric use were removed from the wards and, instead, sterilized placebo gel, perishable 24 h after opening, was available in 100 ml glass bottles. When a woman was in active labor, the attending obstetrician applied 10 ml gel (brought at room temper ature) from the syringe attached to a 14 cm plastic catheter around the portio and into the fornices. This procedure was repeated after 10 h in case delivery had not yet occurred, For this purpose, all syringes were delivered in duplicate.
2,3. Data collection
All parturients were cultured before the application o f any gel. Cotton tipped wooden swabs were used, moistened with Todd-Hewitt broth, with addition of 8% lecithin and 3% Tween 80 to inactivate any chlorhexidine remnants absorbed in the swab [23] . An anorectal swab was first taken, after which a second swab was used to sample the posterior half or the introitus. Using a sterile speculum, a third swab was rotated 360° in the cervical os to obtain a cervical specimen. Ear, pharynx and umbilicus o f all neonates were cultured directly after birth.
All swabs were stored at 4"( ' and inoculated within 24 h in the same bacteriological laboratory, The following media were used to plate the swabs semiquantitatively:
5% defibrmated sheep blood agar (48 h at 36°C), Gasman agar witli 10 units/ml bacitracin and 5% defibrmated rabbit blood (anaerobically, 48 h at 36°C) and Sabouraud agar (72 h at 30 C). Sabouraud agar and
Of the 1020 participating women, 522 were enrolled in Casman agar were used to deteet yeasts and one hospital and 498 in the other. Thirty-nine were not Haemophilus injftwttztit*, respectively, the latter also evaluated because cultures were incomplete or lost, or being recognized as an important cause ol neonatal in-delivery took place before any gel could have been apfections [24] . 
Statistics
The Kruskal-Wallis test, Fisher's exact test, logistic regression analysis and repeated measurement analysis of categorical data [25] were used for statistical analyses.
3, Results
m Table i Characteristics of enrolled parturients by group assignment lective enrichment broth consisting of Todd-Hewitt broth with 15/tg nalidixic acid per ml and 8/tg gen-placebo group and 326 to the control group. In total, 19 tamicin per ml. After overnight incubation at 36°C, the (1.9%) twin pregnancies and 41 (4.2%) premature delivswabs were plated on blood agar and incubated at 36°C eries were enrolled. Table 1 
summarizes a number o f for another 24 h, The growth density of microorganisms characteristics o f the three groups; no significant differ-(1,2, 3 or 4), expressed as growth in the corresponding streak area, on the directly plated agar plates was deter mined. Growth density 0 was scored if GBS were only isolated from the enrichment broth (or if only 1-2 col onies of other species were grown on blood agar). The identification o f GBS was confirmed by a positive CAMP-reaction, abscnec o f a zone o f inhibition around a bacitracin disc (0.04 units) on Casman blood agar (18-24 h at 36,'( '), and a group B latex agglutination test (Streptex, Wellcome Diagnostics).
Standard forms were used to record the data of moth er and child. Prenatal data included information on age, ethnic origin, obstetric history, assessment of gestational age, use of drugs, alcohol and nicotine, any loss of blood, toeolysis, anemia and diabetes mellitus or gesta tional diabetes.
In addition to the usual parameters of labor and deliv ery, data also included time o f rupture of membranes, admission to the delivery ward and application(s) of gel. Moreover, the following data were recorded: cervical dilatation at the moment o f application of gel, number of vaginal examinations, use of internal monitoring, fetal blood sampling and infection parameters. Initial infant data were collected and whether the infant receiv ed intensive, special or regular care. Women and infants were followed up during their hospital stay with special attention to infectious pro- ences were found. Overall, GBS carriership was established in 190 (19,4%) of 981 women, 108 (56.8%) of the carriers being heavily colonized (growth density 3 or 4). Anorectal, introital and cervical colonization was found in 169 (88.9%), 139 (73.2%) and 112 (58.9%) of carriers, respectively; the differences being statistically significant (P < 0.001 [25] ). Genitals plus anorectum were colonized in 67.9%, only the genitals in 11.1% and just the anorectum in 21.1% o f the carriers.
Pregnancy characteristics o f intrapartum GBS car riers were compared to that o f non-carriers (Table 2) . N o differences in obstetric histories were found, nor in the use of tocolytic therapy during pregnancy or in ges tational age at delivery. More insulin-dependent diabetes mellitus was found in the GBS carrier group (two-tailed Fisher's exact test, P = 0.05), while non carriers suffered from anemia more often (two-tailed Fisher's exact test, P = 0.04).
Group assignment o f GBS carriers did not significant ly influence the clinical characteristics o f deliveries and infants at birth (Table 3 ). In 98.4% o f the chlorhexidinegroup-assigned GBS carriers, the gel was applicated more than 30 min before birth. A second gel application was given to 5.8% of the total chlorhexidine group and 4.9% o f the placebo group. Gel was administered after the membranes had ruptured in 70.0% o f GBS carriers. 
The median interval between admission and the first application o f gel was 3.5 h for both gel-treated groups. The median cervical dilatation at the first application of gel was 4 cm. N o significant differences in infection par ameters were detected between the three groups of GBS colonized parturients. Group assignment had no influ ence on the condition o f infants born of GBS carriers, although significantly more infants from both the Chlorhexidine and control group were admitted to the special care unit, as compared to the neonates from the placebo group (two-tailed Fisher's exact test, P = 0.012).
The vertical transmission rate of S. agalactiae was lower in the Chlorhexidine group, but the difference did not reach significance (two-tailed Fisher's exact test, P = 0.069; Table 4 ). When testing the transmission rate for the chlorhexidine group (52.4%) versus that for the combined placebo plus control group (69.3%), the dif ference of 16.9% (95% confidence interval (Cl) 2.2-31.6%) was significant (two-tailed Fisher's exact test, P = 0.026; one-tailed Fisher's exact test, P = 0.017). These transmission rates resulted in 10.1%, 15.2% and 11.7%) neonatal GBS colonization in the chlorhexidine, placebo and control group, respectively. Logistic regression analysis for the maternal carriers, with correction for the treatment group (no interac-tions), reveals the introitus as the colonization site yielding the highest GBS vertical transmission rate (odds ratio 10.2; 95% Cl 4.3-24.5%).
No significant differences in transmission rates o f E, coli, S. aureus and C. albicans were found between the three groups (two-tailed Fisher's exact test; Table 4 ). Overall, transmission rates of microorganisms declined in the following order: S . agalactiae (63.5%), S. aureus (53.9%), E. coli (35.6%) and C. albicans (32.7%) . The degree of neonatal colonization with the various microorganisms, reflected by the sumscore of the growth densities for all three culture-sites, did not differ significantly among the three groups (Kruskal-Wallis test; Table 4 ). Haemophilus species (not associated with morbidity) were cultured from two women in the chlorhexidine group: H influenzae type B only from one cervix and Haemophilus parainfluemae from the in troitus of both women. Only the ear of one symptomfree neonate, bom of a non-colonized woman from the i control group, was colonized with H. influenzae (non type B). Microbial growth, which can be considered as a quality control of sample and culture techniques, was present in 95.1% of all maternal cultures (n = 2943) and in 90.5% of neonatal cultures from the placebo plus con trol groups (n = 1962).
Follow-up data until three months postpartum were obtained from all 981 mother-infant pairs. N o signifi cant differences between the three groups of GBS col onized mothers were detected, regarding the incidence of temperature >38°C, endometritis, wound infection (following perineal rupture, episiotomy, or caesarean section), antibiotic therapy and various other infectious complications. Similarly, there were no significant dif ferences between the control groups of GBS carriers and non-carriers (n = 269). No cases of endometritis or wound infection were registered among GBS carriers. Among the non-carriers (n = 791), four suffered from endometritis and two from infected wounds, caused by other pathogens than GBS.
There was no mortality among the infants born o f GBS carriers. One male infant (3635 g at 295 gestational days), born of a heavily colonized GBS carrier from the chlorhexidine group, suffered from early onset GBS sep sis and was discharged after successful treatment with ampicillin and gentamicin. The membranes had rup tured 3 h before the application of gel and some signs o f infection were present during labor. Another boy, whose mother was heavily colonized with E. coli but not with GBS and was treated with placebo gel, suffered from pneumonia (E. coli and S . aureus) and was also suc cessfully treated with ampicillin and gentamicin without further sequelae.
Two children bom of non-carriers died: a small-forgestational-age term boy at age 3 months died from cot death and a girl died within the first week due to transposition of the great vessels.
There were no significant differences regarding the in- 
Discussion
Colonization rates for the anorectum, introitus and cervix support the concept that the lower gastrointestinal tract is the principal reservoir for GBS.
The introitus seems the most suitable site for screening, in view o f the high GBS vertical transmission rate and relatively high GBS isolation rate at this location.
Maternal diabetes was identified as a risk factor for GBS colonization, as earlier reported by Baker [26] .
In contrast to our pilot study [20] , a modest reduction in vertical transmission rate o f 5. agalactiae by chlorhexidine gel was found in the present, first rando mized, study. In the non-randomized pilot study, how ever, the vagina was cleaned with saline before the application o f the 0. o f serum, blood, pus and other organic matter [17] . This problem can be overcome by using a sufficiently high concentration [18] . The chlorhexidine concentration used in our study was 600 times or more the minimal bactericidal concentration for GBS [28] and at least as high as in other clinical studies [19, 20, 22] .
Preferably, chlorhexidine is applicated before rupture of the membranes, as the risk for ascending colonization and infection of the genital tract increases substantially after membrane rupture. The prevalence of positive gen ital cultures for GBS is significantly lower immediately after rupture of the membranes [29] . This may be due to a 'wash out5 effect and/or inherent bacteriostatic proper ties of amniotic fluid [30] . The duration of this effect is not known. Reduction of vaginal pathogens by chlorhexidine and thereupon amniorrhexis would seem most beneficial. In the present study, the chlorhexidine gel was given in only 30% of GBS carriers before the membranes ruptured. In these cases, transmission oc curred in 44%; transmission occurred in 56% when gel was applicated after the membranes ruptured. For the placebo group, these percentages were 77% and 69%, respectively.
The effect of chlorhexidine might be increased by earlier application, preferably before membrane rup ture, and possibly by increasing the concentration and/or quantity. Randomizing patients during preg nancy instead of during labor could probably have gain ed time in this trial. Earlier application in routine use is possible because there is no need for the time-consuming process of enrolling, randomizing and culturing of a trial.
We conclude that vaginal disinfection with 0.3% chlorhexidine gel during labor modestly reduces vertical transmission of GBS. This raises the question of whether this reduction is of sufficient clinical impor tance to implement chlorhexidine disinfection in clinical practice. We theorize that the qualitative and quantita tive reduction in vertical transmission in the Netherlands (195 000 deliveries/year) may subsequently lead to a reduction by 4 -6 2 cases of an estimated annual 195 cases of early onset GBS sepsis. The costs of imple mentation can roughly be calculated analogous to The costs of a comparable product as catheter lubricant. This is manufactured at an industrial scale and purchas ed at prices of about Dfl. 2.50 per ready to use unit. The price of such products is mainly dependent on the costs of manufacturing and the applicator tip, whereas the in gredients contribute less than 5% to the final costs. The use of 250 000 packages/year would cost Dfl. 0,63 million. The financial benefit would result from fewer admissions to neonatal intensive care units (average Dfl. 30 000/neonate) and less handicapped children (up to Dfl. 2 million/lifetime). Assuming that early onset GBS sepsis will leave 1 out o f 8 neonates severely handicap ped, the total benefit would range between Dfl. 1,12-17.36 million/year. Because the method is costeffective, simple and safe, it should be considered for
